Dr. Magliocco on Pathologists in the Treatment of Melanoma

Anthony M. Magliocco, MD
Published: Thursday, Oct 10, 2013

Anthony M. Magliocco, MD, chair of pathology, executive director of esoteric labs at Moffitt Cancer Center, discusses the role of the pathologist in the treatment of a patient with melanoma.

Behind the primary practitioner, who is working with the patient directly, there is a team of experts that can help guide treatment by providing information on molecular genetics, therapy, and radiation oncology.

Magliocco says that a molecular pathologist can help a primary practitioner understand a tumor, the best technology platform to use, how to interpret data, and more. It is also essential for a primary practitioner to become familiar with the laboratories they are working with so that they can better understand the technologies, how they are changing, and what impact they can have on patients.

Anthony M. Magliocco, MD, chair of pathology, executive director of esoteric labs at Moffitt Cancer Center, discusses the role of the pathologist in the treatment of a patient with melanoma.

Behind the primary practitioner, who is working with the patient directly, there is a team of experts that can help guide treatment by providing information on molecular genetics, therapy, and radiation oncology.

Magliocco says that a molecular pathologist can help a primary practitioner understand a tumor, the best technology platform to use, how to interpret data, and more. It is also essential for a primary practitioner to become familiar with the laboratories they are working with so that they can better understand the technologies, how they are changing, and what impact they can have on patients.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x